Home
Conditions
Acquired Immunodeficiency Syndrome

Clinical trial condition

Acquired Immunodeficiency Syndrome

Explore clinical trials studying Acquired Immunodeficiency Syndrome. Study availability and eligibility vary by location and protocol.

2,558 public trials 178 recruiting studies

Refine in advanced search Browse all conditions

Acquired Immunodeficiency Syndrome trial results

Completed

To Reach Unrestricted Services for Transgender Women

NCT03877497

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +19 more
Locations: Florida International University Miami, Florida, United States

University of Central Florida Orlando, Florida, United States

View Trial Details

Completed

Patient Actor Training to Improve HIV Services for Adolescents in Kenya

NCT02928900

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: HIV care facility 6 Homa Bay, Kenya

HIV care facility 3 Kiambu, Kenya

HIV care facility 4 Kiambu, Kenya

HIV care facility 5 Kisumu, Kenya

View Trial Details

Completed

Instacare - Rapid ART Initiation Among Persons With HIV and Out of Care

NCT04240691

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: UC San Diego AntiViral Research Center (AVRC) San Diego, California, United States

UC San Diego Owen Clinic San Diego, California, United States

View Trial Details

Completed

Systems Analysis and Improvement Approach for the Hypertension Care Cascade

NCT04088656

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cardiovascular Diseases, +17 more
Locations: Hospital Distrital de Catandica Catandica, Manica Province, Mozambique

Centro de Saude 1 de Maio Chimoio, Manica Province, Mozambique

Centro de Saude 7 de Abril Chimoio, Manica Province, Mozambique

Centro de Saude Eduardo Mondlane Chimoio, Manica Province, Mozambique

View all 16 locations

View Trial Details

Completed

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes (UH3)

NCT05007717

Conditions: Acquired Immunodeficiency Syndrome, Adolescent Behavior, Behavior, +16 more
Locations: Asumbi Health Centre Homa Bay, Kenya

Homa Hills Health Centre Homa Bay, Kenya

Kendu Adventist Hospital Homa Bay, Kenya

Marindi Sub County Referral Hospital Homa Bay, Kenya

View all 24 locations

View Trial Details

Completed

Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study

NCT05896748

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Macon, Georgia, United States

GSK Investigational Site Austin, Texas, United States

GSK Investigational Site Bellaire, Texas, United States

GSK Investigational Site Dallas, Texas, United States

View all 30 locations

View Trial Details

Completed

Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

NCT03800381

Conditions: Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +21 more
Locations: Kwame Nkrumah University of Science and Technology Kumasi, Ghana

View Trial Details

Completed

Innovative Strategy to Offer Online Test and Treat for Thai MSM/TG

NCT03203265

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: The Thai Red Cross AIDS Research Centre Pathum Wan, Bangkok, Thailand

View Trial Details

Completed

Leveraging mHealth and Peers to Engage African- Americans and Latinxs in HIV Care (LEAN)

NCT03934437

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Baltimore City Health Department Baltimore, Maryland, United States

View Trial Details

Completed

Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)

NCT02403674

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Acquired Immunodeficiency Syndrome

Acquired Immunodeficiency Syndrome trial results

Related conditions